Ocular Therapeutix, Inc. (OCUL) quarterly cash flow statement — complete operating, investing & financing history
Ocular Therapeutix, Inc. (OCUL) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -67.27M | -65.99M | -54.25M | -50.73M | -55.24M | -44.67M | -39.43M | -36.56M | -24.8M | -33.89M | -22.45M | -12.92M | -20.07M | -19.97M | -16.96M | -13.17M | -10.88M | -18.6M | -15.15M | -12.98M |
| Operating CF Margin % | -499.24% | -611.9% | -409.43% | -348.77% | -410.42% | -417.56% | -230.82% | -237.01% | -150.85% | -229.37% | -151.71% | -85.64% | -132.19% | -149.34% | -120.48% | -110.06% | -88.67% | -141.05% | -123.11% | -106.82% |
| Operating CF Growth % | -21.79% | -47.73% | -37.59% | -38.75% | -122.72% | -31.82% | -75.6% | -183.05% | -23.55% | -69.66% | -32.41% | 1.92% | -84.58% | -7.38% | -11.91% | -1.44% | 45.77% | -7.15% | -142.6% | 4.95% |
| Net Income | -78.76M | -88.61M | -64.65M | -69.42M | -67.81M | -64.05M | -48.39M | -36.49M | -43.78M | -64.85M | -29.22M | -516K | -20.68M | -30.32M | -15.54M | -24.19M | -18.77M | -12.54M | -3.85M | 2.66M |
| Depreciation & Amortization | 1.85M | 1.28M | 1.25M | 1.07M | 1.03M | 981K | 951K | 959K | 956K | 920K | 958K | 890K | 652K | 483K | 491K | 509K | 552K | 557K | 570K | 594K |
| Stock-Based Compensation | 14.65M | 15.58M | 11.36M | 11.69M | 9.68M | 10.46M | 7.2M | 6.64M | 11.29M | 7.98M | 4.33M | 4.51M | 4.41M | 4.57M | 4.23M | 4.24M | 4.28M | 4.21M | 3.84M | 3.76M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -49K | 4.79M | -100K | 2.21M | 1.32M | 2.41M | -47K | -6.46M | 3.6M | 35.07M | 8.03M | -24.02M | 1.25M | 7.79M | -4.01M | 2.36M | -1.57M | -5.77M | -14.68M | -22.68M |
| Working Capital Changes | -4.96M | 962K | -2.1M | 3.73M | 552K | 5.53M | 858K | -1.21M | 3.13M | -13.01M | -6.55M | 6.22M | -4.58M | -2.5M | -2.13M | 3.91M | 4.63M | -5.05M | -1.03M | 2.69M |
| Change in Receivables | -5.91M | 6.3M | 118K | -356K | -5.19M | 7.17M | -2.15M | -3K | -3.69M | -367K | -2.59M | 3.72M | -6.18M | 201K | -1.52M | 680K | 2.73M | -2.07M | -1.58M | -818K |
| Change in Inventory | -89K | -173K | -76K | -449K | 230K | -229K | -635K | 142K | 27K | -269K | -48K | -53K | 62K | -292K | -429K | -45K | -142K | -108K | -28K | -110K |
| Change in Payables | 196K | 3.72M | -1.35M | -1.27M | 1.73M | 7K | 112K | 297K | -2.42M | 1.69M | 656K | 247K | -1.34M | 1.02M | -1.12M | 1.31M | 304K | -1.11M | 366K | 175K |
| Cash from Investing | -3.37M | -4.66M | -2.84M | -5.99M | -1.11M | -1.93M | -202K | -89K | -742K | -255K | -459K | -259K | -1.99M | -3.38M | -2.15M | -794K | -495K | -276K | -631K | -276K |
| Capital Expenditures | -3.37M | -4.66M | -2.84M | -5.99M | -1.25M | -1.93M | -202K | -89K | -742K | -255K | -459K | -259K | -1.99M | -3.38M | -2.15M | -794K | -495K | -276K | -631K | -276K |
| CapEx % of Revenue | 24.99% | 43.23% | 21.43% | 41.21% | 9.25% | 18.07% | 1.18% | 0.58% | 4.51% | 1.73% | 3.1% | 1.72% | 13.1% | 25.27% | 15.28% | 6.64% | 4.04% | 2.09% | 5.13% | 2.27% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 130K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 2.58M | 294K | 449.38M | 10.36M | 97.81M | 4.18M | 4.51M | 4.18M | 2.2M | 321.22M | 108.17M | 57.12M | 9.64M | 78K | 458K | 374K | 493K | 129K | 667K | 679K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26.13M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 2.58M | 294K | 449.38M | 10.36M | 97.81M | 0 | 524K | 0 | 492K | 316.35M | 107.73M | 770K | 8.82M | 0 | 0 | 0 | 0 | 0 | 667K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 4.18M | 3.99M | 4.18M | 1.7M | 4.87M | 441K | 82.47M | 821K | 78K | 458K | 374K | 493K | 129K | 0 | 679K |
| Net Change in Cash | -68.06M | -70.36M | 392.29M | -46.36M | 41.45M | -42.42M | -35.12M | -32.47M | -23.35M | 287.08M | 85.26M | 43.94M | -12.42M | -23.27M | -18.65M | -13.59M | -10.88M | -18.75M | -15.12M | -12.58M |
| Free Cash Flow | -70.64M | -70.66M | -57.09M | -56.72M | -56.48M | -46.6M | -39.63M | -36.65M | -25.54M | -34.14M | -22.91M | -13.18M | -22.07M | -23.35M | -19.11M | -13.96M | -11.37M | -18.88M | -15.78M | -13.26M |
| FCF Margin % | -524.22% | -655.12% | -430.85% | -389.98% | -419.67% | -435.63% | -232% | -237.59% | -155.37% | -231.1% | -154.81% | -87.36% | -145.3% | -174.61% | -135.76% | -116.7% | -92.7% | -143.14% | -128.24% | -109.09% |
| FCF Growth % | -25.06% | -51.61% | -44.05% | -54.76% | -121.12% | -36.5% | -72.96% | -178.16% | -15.77% | -46.21% | -19.91% | 5.64% | -94.05% | -23.71% | -21.06% | -5.32% | 43.67% | -7.76% | -142.87% | 4.43% |
| FCF per Share | -0.31 | -0.32 | -0.26 | -0.31 | -0.33 | -0.28 | -0.24 | -0.22 | -0.15 | -0.26 | -0.21 | -0.15 | -0.28 | -0.30 | -0.23 | -0.18 | -0.14 | -0.23 | -0.19 | -0.16 |
| FCF Conversion (FCF/Net Income) | 0.85x | 0.74x | 0.84x | 0.73x | 0.81x | 0.70x | 0.81x | 1.00x | 0.57x | 0.52x | 0.77x | 25.03x | 0.97x | 0.66x | 1.09x | 0.54x | 0.58x | 1.48x | 3.94x | -4.89x |
| Interest Paid | 0 | 2.19M | 2.24M | 2.34M | 2.31M | 2.14M | 3.33M | 2.6M | 2.63M | 12.97M | 2.6M | 1.34M | 0 | 701K | 626K | 531K | 495K | 495K | 489K | 378K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |